Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Cisplatin and 5-fluorouracil in Recurrent or Metastatic NPC
NCT00747799Phase 2Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2009
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Jan 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00747799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747799.